PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8800366-0	1996	Effect of C-peptide administration on whole body glucose utilization in STZ-induced diabetic rats.	Glucose	49-56	insulin 2	Rattus norvegicus	10-19	
8800366-0	1996	Effect of C-peptide administration on whole body glucose utilization in STZ-induced diabetic rats.	Streptozocin	72-75	insulin 2	Rattus norvegicus	10-19	
8800366-1	1996	Recent studies suggest that C-peptide stimulates glucose transport in isolated skeletal muscle.	Glucose	49-56	insulin 2	Rattus norvegicus	28-37	
8800366-6	1996	The metabolic clearance rate of glucose (MCR) for the diabetic rats receiving C-peptide (12.0 +/- 1.0 mL kg-1 min-1) was significantly (P < 0.01) higher than that in the diabetic rats given saline (6.3 +/- 0.7 mL kg-1 min-1) or a randomly scrambled C-peptide (7.8 +/- 1.3 mL kg-1 min-1) at low-dose insulin infusion but not at the high-dose insulin infusion.	Glucose	32-39	insulin 2	Rattus norvegicus	78-87	
8800366-6	1996	The metabolic clearance rate of glucose (MCR) for the diabetic rats receiving C-peptide (12.0 +/- 1.0 mL kg-1 min-1) was significantly (P < 0.01) higher than that in the diabetic rats given saline (6.3 +/- 0.7 mL kg-1 min-1) or a randomly scrambled C-peptide (7.8 +/- 1.3 mL kg-1 min-1) at low-dose insulin infusion but not at the high-dose insulin infusion.	Glucose	32-39	CD59 molecule (CD59 blood group)	Homo sapiens	110-115	
8800366-6	1996	The metabolic clearance rate of glucose (MCR) for the diabetic rats receiving C-peptide (12.0 +/- 1.0 mL kg-1 min-1) was significantly (P < 0.01) higher than that in the diabetic rats given saline (6.3 +/- 0.7 mL kg-1 min-1) or a randomly scrambled C-peptide (7.8 +/- 1.3 mL kg-1 min-1) at low-dose insulin infusion but not at the high-dose insulin infusion.	Glucose	32-39	CD59 molecule (CD59 blood group)	Homo sapiens	221-226	
8800366-6	1996	The metabolic clearance rate of glucose (MCR) for the diabetic rats receiving C-peptide (12.0 +/- 1.0 mL kg-1 min-1) was significantly (P < 0.01) higher than that in the diabetic rats given saline (6.3 +/- 0.7 mL kg-1 min-1) or a randomly scrambled C-peptide (7.8 +/- 1.3 mL kg-1 min-1) at low-dose insulin infusion but not at the high-dose insulin infusion.	Glucose	32-39	insulin 2	Rattus norvegicus	252-261	
8800366-6	1996	The metabolic clearance rate of glucose (MCR) for the diabetic rats receiving C-peptide (12.0 +/- 1.0 mL kg-1 min-1) was significantly (P < 0.01) higher than that in the diabetic rats given saline (6.3 +/- 0.7 mL kg-1 min-1) or a randomly scrambled C-peptide (7.8 +/- 1.3 mL kg-1 min-1) at low-dose insulin infusion but not at the high-dose insulin infusion.	Glucose	32-39	CD59 molecule (CD59 blood group)	Homo sapiens	221-226	
8800366-6	1996	The metabolic clearance rate of glucose (MCR) for the diabetic rats receiving C-peptide (12.0 +/- 1.0 mL kg-1 min-1) was significantly (P < 0.01) higher than that in the diabetic rats given saline (6.3 +/- 0.7 mL kg-1 min-1) or a randomly scrambled C-peptide (7.8 +/- 1.3 mL kg-1 min-1) at low-dose insulin infusion but not at the high-dose insulin infusion.	Sodium Chloride	193-199	insulin 2	Rattus norvegicus	78-87	
8800366-8	1996	These results thus demonstrate that C-peptide has the capacity to increase glucose utilization in STZ-induced diabetic rats.	Glucose	75-82	insulin 2	Rattus norvegicus	36-45	
8800366-8	1996	These results thus demonstrate that C-peptide has the capacity to increase glucose utilization in STZ-induced diabetic rats.	Streptozocin	98-101	insulin 2	Rattus norvegicus	36-45